Effect of garlic supplementation on oxidized low density lipoproteins and lipid peroxidation in patients of essential hypertension

Molecular and Cellular Biochemistry

Volumn 266, Issue 1-2, 2004, Pages 109-115

  Dhawan, Veena ^a   Jain, Sanjay ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Garlic; Hypertension; Lipoproteins; Oxidative stress

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ANTIOXIDANT; BIOLOGICAL MARKER; CHOLESTEROL; GARLIC EXTRACT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ARTICLE; BLOOD PRESSURE REGULATION; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG MECHANISM; ESSENTIAL HYPERTENSION; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; HYPERCHOLESTEROLEMIA; IN VIVO STUDY; LIPID BLOOD LEVEL; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; OXIDATIVE STRESS; PROSTAGLANDIN BLOOD LEVEL; PROSTAGLANDIN URINE LEVEL; RANDOMIZED CONTROLLED TRIAL; SHORT COURSE THERAPY; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; BLOOD PRESSURE; DIETARY SUPPLEMENTS; F2-ISOPROSTANES; FEMALE; GARLIC; HUMANS; HYPERTENSION; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATION-REDUCTION; OXIDATIVE STRESS; PLANT EXTRACTS; REACTIVE OXYGEN SPECIES;

ALLIUM SATIVUM; TOSCANA VIRUS;

EID: 9444281486     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000049146.89059.53     Document Type: Article

References (47)

1. Harunobu A, Brenda LP, Hiromichi M, Shigeo K, Yoichi I: Recent advances on the nutritional effects associated with the use of garlic as a supplement. J Nutr 131: 955S-962S, 2001
2. Qureshi AA, Din ZZ, Abuirmeileh N, et al.: Suppression of avian hepatic lipid metabolism by solvent extracts of garlic: Impact on serum lipids. J Nutr 113: 746-755.
3. Chang ML, Johnson MA: Effect of garlic on carbohydrate metabolism and lipid synthesis in rats. J Nutr 110: 931-968, 1980
4. Jain AK, Vargas R, Gotzkowsky S, Mcmohan FG: Can garlic reduce levels of serum lipids? A controlled clinical study. Am J Med 94: 632-635, 1993
5. Steiner M, Khan AH, Holbert D, Lin RI: A doubleblind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on good lipids. Am J Clin Nutr 64: 866-870, 1996
6. Sendl A, Schliack M, Loser R, et al.: Inhibition of cholesterol synthesis in vitro by extracts and isolated compounds prepared from garlic and wild garlic. Atherosclerosis 94: 79-85, 1992
7. Gebhardt R: Multiple inhibitory effects of garlic extracts on cholesterol biosynthesis in hepatocytes. Lipids 28: 613-619, 1993
8. Agarwal KC: Therapeutic actions of garlic constituents. Med Res Rev 16: 111-124, 1996
9. Rahman K: Historical perspectives on garlic and cardiovascular disease. J Nutr 131: 977S-979S, 2001
10. Stevenson C, Pittler MH, Ernst E: Garlic for treating hypercholesterolemia Ann Intern Med 133: 420-429, 2000
11. Foushee DB, Ruffin J, Banerjee U: Garlic as a natural agent for the treatment of hypertension: A preliminary report. Cytobios 34: 145-152, 1982
12. Pedraza CJ, Tapia E, Medina Campos ON: Garlic prevents hypertension induced by chronic inhibition of nitric oxide synthesis. Life Sci 62: 71-77, 1998
13. Steiner M, Li W: Aged garlic a modulator of cardiovascular risk factors: A dose finding study on the effects of AGE on platelet function. J Nutr 131: 980S-984S, 2001
14. Bordia A, Verma SK, Srivastava KC: Effect of garlic (Allium sativum on blood lipids, blood sugar, fibrinogen and fibrinolytic activity in patients of coronary heart disease. Prostaglandins Leuk Essential Fatty Acids 58: 257, 1998
15. Russo C, Olivieri O, Girelli D, Faccini G, Zenari LM, Lombardi S, Corrocher R: Antioxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens 16: 1267-1271, 1998
16. Dhalla NS, Temsah RM, Netticadan T: Role of oxidative stress in cardiovascular diseases. J Hypertens 18: 655-673, 2000
17. Cathcart MK, Morel DW, Chisolm GM: Monocytes and neutrophils oxidize low density lipoprotein, making it cytotoxic. J Leuko C Biol 38: 341-350, 1985
18. Steinberg D, Parthsarathy S, Carew TE, Witzum JL: Beyond Cholesterol: Modification of low density lipoprotein that increase in atherogenicity. N Engl J Med 320: 915-924, 1989
19. Darley-Usmar VM, Hogg N, O'Leary VJ, Wilson MT, Moncada S: The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein. Free Radic Res Commun 17: 9-20, 1992
20. Rosenfield ME, Painskiw, Yla-Herthala S, Carew TE: Macrophages, endothelial cells and lipoprotein oxidation in the pathogenesis of atherosclerosis. Toxicol Pathol 18: 566-571, 1990
21. Kuzuya M, Naito M, Funaki C, Mayashi T, Asai K, Kuzuya F: Lipid peroxide and transiton metals are required for the toxicity of oxidised low density lipoprotein to cultured endothelial cells. Biochem Biophys Acta 1096: 155-561, 1991
22. Marletha MA, Yoon PS, Iyengar R, Lear CD, Wishroik JS: Macrophage oxidation of l-arginine to nitrite and nitrate : Nitric oxide is an intermediate. Biochemistry 27: 8706-8711, 1988
23. Barton M, Haudenschild CC: Endothelium and atherogenesis: Endothelial therapy revisited. Cardiovasc Phamacol 38 (suppl): 523-525, 2001
24. Sigurdardotitir V, Fagerberg B, Hulthe J: Circulating oxidized low density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58 year old men. J Intern Med 252: 440-447
25. Orekhov AN, Pivovarova CM, Testov VV: Garlic powder tablets reduce atherogenicity of low-density lipoproteins. A placebo-controlled double-blind study. Nutr Metab Cardiovasc Dis 6: 21-31, 1996
26. Prasad K, Laxdal VA, Yu M, Raney BL: Antioxidant activity of allicin, an active principle in garlic. Mol Cell Biochem 148: 183, 1995
27. 2a in smoking and non-smoking men and women. J Nutr 132: 168-171, 2002
28. Marrow JD, Harris TM, Roberts LJ II: Non-cyclooxygenase oxidative formation of a series of novel Prostaglandins. Analytical ramification of measurement of eicosanoids. Anal Biochem 184: 1-10, 1996
29. 2[i#a generation during coronary reperfusion. A potential quantitative marker of oxidative stress in vivo. Br J Clin Pharmacol 42: 15-19, 1996
30. JNC VI - The Sixth Report of Joint National Committee on Prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med 157: 2401-2445, 1997
31. 2α and platelet activation in diabetes mellitus: Effects of improved metabolic control and vitamin E supplementation. Circulation 99: 224-229, 1999
32. Benzie Iris FF, Stein JJ: Ferric reducing antioxidant power assay: Direct measurement of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Anal Biochem 239: 15-27, 1996
33. Friedwald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18: 499-502, 1977
34. Expert Group: The Fifth Report of The Joint National Committee on detection, evaluation and treatment of high blood pressure. Arch Intern Med 153: 154-186, 1993
35. Whetton PK: Epidemiology of hypertension. Lancet 344: 101-106, 1994
36. Mader FH: Treatment of hyperlipidemia with garlic powder tablets. Arzneimittelforschung 40: 1111-1116, 1990
37. Jain AK, Vargas R, Gotzkowsky S, McMohan FG: Can garlic reduce levels of serum lipids? A controlled clinical study. Am J Med 94: 632-635, 1993
38. Pedraza-Chaverri J, Tapia E, Medina Campus ON, et al: Garlic prevents hypertension induced by chronic inhibition of NO synthesis. Life Sci 62: 71-72, 1998
39. + channel opening by garlic in human vascular smooth muscle cell membranes. Phytother Res 12: S149-S151, 1998
40. Suetsuna K: Isolation and characterization of angiotensin I converting enzyme inhibitor dipeptides derived from Allium sativum L. (garlic). J Nutr Biochem 9: 415-419, 1998
41. Silaqy CA, Neil HAW. A meta analysis of the effect of garlic on blood pressure. J Hypertens 12: 463-468, 1994
42. 2+-induced oxidative modification of low density lipoprotein. Planta Med 63: 263-264, 1997
43. Phelps S, Harris W: Garlic supplementation and lipoprotein oxidative susceptibility. Lipids 28: 475-477, 1993
44. Reilly M, Delanty N, Lawson JA, Fitzgerald GA: Modulation of chronic oxidant stress in vivo in chronic cigarette smokers. Circulation 94: 19-25, 1996
45. Reilly MP, Pratico D, Delanty N, Delanty N, Di Minno G, Tremoli E, Rader D, et al.: Increased formation of distinct F2 isoprostane in hypercholesterolemia. Circulation 28: 22-28, 1998
46. 2γa levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Lett 368: 225-229, 1995
47. 2 isoprostane as an index of lipid peroxidation does not appear to be confounded by diet. Free Radic Res 33: 115-127, 2000